Achilles Therapeutics

1.39
0.01 (0.72%)
At close: Mar 03, 2025, 3:59 PM
1.38
-0.36%
After-hours: Mar 03, 2025, 04:50 PM EST

Achilles Therapeutics Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Cash & Equivalents 131.54M 173.34M 266.32M 177.85M 97.59M 10.68M
Short-Term Investments 1.00 n/a n/a n/a 265.00 n/a
Long-Term Investments 33K 33K 33K n/a n/a n/a
Other Long-Term Assets 2.21M 3.05M 3.54M 3.01M 34K n/a
Receivables 10.35M 16M 11.17M 7.34M 4.49M n/a
Inventory 1.00 4.62M 5.13M 1.76M 504K n/a
Other Current Assets 3.74M 7.24M 7.26M 2.61M 981K 2.69M
Total Current Assets 145.63M 196.58M 284.75M 187.8M 103.06M 13.38M
Property-Plant & Equipment 13.54M 20.48M 28.79M 28.11M 2.11M 583K
Goodwill & Intangibles 1.00 -33K -33K n/a n/a n/a
Total Long-Term Assets 15.82M 23.78M 32.36M 31.12M 2.14M 583K
Total Assets 161.46M 220.36M 317.11M 218.92M 105.2M 13.96M
Account Payables 5.63M 5.19M 3.72M 6.31M 902K 129K
Deferred Revenue n/a n/a 9.64M 5.23M 1.79M n/a
Short-Term Debt 3.54M 4.19M 4.48M 3.71M 487K n/a
Other Current Liabilities 7.83M 8.29M 10.91M 6.59M 2.47M 1.16M
Total Current Liabilities 17M 17.99M 19.11M 16.62M 3.86M 1.29M
Long-Term Debt 1.08M 4.39M 7.78M 12.27M n/a n/a
Other Long-Term Liabilities 1.01M 933K 691K 652K n/a n/a
Total Long-Term Liabilities 2.09M 5.32M 8.47M 12.92M n/a n/a
Total Liabilities 19.09M 23.31M 27.58M 29.55M 3.86M 1.29M
Total Debt 4.62M 8.58M 12.26M 15.98M 487K n/a
Common Stock 182K 54K 54K 25K 14K n/a
Retained Earnings -259.95M -190.29M -119.11M -58.01M -24.81M -10.82M
Comprehensive Income -13.07M -21.7M 6.64M 12.32M 8.11M -395K
Shareholders Equity 142.37M 197.04M 289.53M 189.37M 101.35M 12.67M
Total Investments 33K 33K 33K n/a 265.00 n/a